학술논문
P15.03 A Phase 1/1b Study of Lazertinib as Monotherapy and in Combination with Amivantamab in Advanced EGFR-Mutated NSCLC
Document Type
Abstract
Author
Source
In Journal of Thoracic Oncology March 2021 16(3) Supplement:S344-S345
Subject
Language
ISSN
1556-0864